
Prevalent Pregnancy, Biological Sex, and Virologic Response to Antiretroviral Therapy
Author(s) -
Daniel Westreich,
Denise Evans,
Cindy Firnhaber,
Pappie Majuba,
Mhairi Maskew
Publication year - 2012
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e318256b310
Subject(s) - medicine , hazard ratio , proportional hazards model , pregnancy , confidence interval , body mass index , cohort , obstetrics , cohort study , viral load , immunology , human immunodeficiency virus (hiv) , genetics , biology
Pregnancy is a common indication for initiation of highly active antiretroviral therapy (HAART) in sub-Saharan Africa. Our objective was to evaluate how pregnancy at treatment initiation predicts virologic response to HAART.